人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊

新发传染病电子杂志 ›› 2018, Vol. 3 ›› Issue (3): 156-159.

• 论著 • 上一篇    下一篇

应用VTQ技术测量肝脾SWV无创评估内镜下硬化治疗乙肝肝硬化重度食管静脉曲张疗效的临床研究

包明稳, 董常峰, 冯程, 黄婷, 邱智辉, 朱质斌   

  1. 深圳市第三人民医院,广东 深圳 518020
  • 收稿日期:2018-05-28 出版日期:2018-08-31 发布日期:2020-06-30
  • 通讯作者: 董常峰,Email:dongchangfeng7@163.com
  • 基金资助:
    国家自然科学基金重点项目(61031003)、国家自然科学基金面上项目(81471735,81570552)、深圳市科技计划项目(卫生类)(2016013)

Measurement of hepatic and splenic SWV by VTR technique for assessment of endoscopic sclerotherapy

BAO Ming-wen, DONG Chang-feng, FENG Cheng, HUANG Ting, QIU Zhi-hui, ZHU Zhi-bin   

  1. The Third People’s Hospital of Shenzhen,GuangDong Shenzhen 518020, China
  • Received:2018-05-28 Online:2018-08-31 Published:2020-06-30

摘要: 目的 探讨应用VTQ技术测量肝、脾SWV无创评估内镜下硬化治疗乙肝肝硬化重度食管静脉曲张(esophageal varices,EV)疗效的临床价值。方法 选取拟行镜下硬化治疗的重度EV患者90例,其中59例行镜下硬化治疗(A组),31例行常规胃镜检查(B组)。入院次日收集血常规、肝功能、凝血及超声检查资料,A组分别于镜下治疗前、后一天及术后一月行肝、脾SWV测量,B组分别于胃镜检查前、后行肝、脾SWV测量。A组于术后一月行EUS评估硬化治疗效果。以EUS结果为金标准评价应用肝、脾SWV评估镜下硬化治疗疗效。结果 A组镜下硬化术后肝、脾SWV较术前明显升高[(2.68±0.54)m/s VS(1.98±0.36)m/s,P<0.05;(3.75±0.33)m/s VS(3.15±0.28)m/s,P<0.05]。B组内镜检查前后肝、脾SWV无明显变化,[(1.91±0.43)m/s VS(1.87±0.64) m/s,P>0.05;(3.18±0.36)m/s VS(3.32±0.48)m/s,P>0.05]。术后一月,硬化完全组肝、脏SWV较术后一天稍升高,[(2.88±0.42)m/s VS(2.79±0.38)m/s,P>0.05;(3.81±0.28)m/s VS(3.79±0.26)m/s,P>0.05],硬化不全组肝、脾SWV较术后一天降低[(2.21±0.29)m/s VS(2.49±0.36)m/s,P<0.05)];[(3.15±0.41)m/s VS(3.61±0.38)m/s,P<0.05 ]。以肝SWV2.55m/s作为镜下硬化完全的阈值,敏感度为0.78,特异度为0.73;以脾SWV3.61m/s作为镜下硬化完全的阈值,敏感度为0.89,特异度为0.77。脾SWV评估镜下硬化曲张静脉疗效的AUROC为0.88,预测效能高于肝SWV(AUROC:0.71,Z=2.5,P=0.025)。结论 镜下硬化治疗后可使肝、脾SWV显著上升;应用VTQ技术测量肝、脾SWV可在一定程度上无创评估镜下硬化治疗疗效,脾SWV评估效能高于肝SWV,动态随访肝、脾SWV变化对EV硬化治疗术后临床疗效判断有一定价值。

关键词: 食管静脉曲张, 肝硬化, 超声检查, 弹性成像技术, 实时剪切波弹性成像

Abstract: Objective To evaluate the clinical value of VTQ in the measurement of hepatic and spleen SWV non-invasive evaluation of endoscopic sclerotherapy for severe EV in patients with hepatitis B cirrhosis. Methods Ninety patients with severe EV who underwent sclerotherapy and microsurgery were enrolled, 59 of whom underwent microsurgical sclerotherapy (group A) and 31 underwent routine gastroscopy (group B). The blood, routine liver function, blood coagulation and ultrasonography were collected on the next day. The liver and spleen SWV were measured one day before, one day after and one month after surgery in group A. The liver and spleen underwent SWVmeasurement before and after gastroscopy in group B. Group A underwent EUS to evaluate the effect of sclerotherapy in the first month after surgery. EUS results were used as the gold standard to evaluate the efficacy of subsurgical sclerotherapy with liver and spleen SWV. Results The SWV of liver and spleen in group A was significantly higher than that before operation [(2.68±0.54) m/s VS (1.98±0.36) m/s, P<0.05; (3.75±0.33) m/s VS (3.15±0.28) m/s, P<0.05]. There was no significant change in SWV of liver and spleen before and after endoscopy in group B [[1.91±0.43) m/s VS(1.87±0.64) m/s, P>0.05; (3.18±0.36) m/s VS (3.32±0.48) ) m/s, P>0.05]. At 1 month after operation, the liver and visceral SWV of the hardened group were slightly higher than that of the day after surgery [[2.88±0.42] m/s VS (2.79±0.38) m/s, P>0.05; (3.81±0.28) m/s VS (3.79±0.26) m/s, P>0.05], SWV of liver and spleen in the incomplete group was lower than that in the day after surgery [(2.21±0.29) m/s VS(2.49±0.36) m/s, P<0.05 ]; [(3.15±0.41) m/S VS (3.61±0.38) m/s, P<0.05]. The SWV 2.55m/s was used as the threshold for complete hardening under the microscope. The sensitivity was 0.78 and the specificity was 0.73. The spleen SWV 3.61m/s was used as the threshold for complete hardening under the microscope. The sensitivity was 0.89 and the specificity was 0.77. The AUROC of the spleen SWV for the evaluation of subsurgical varicose veins was 0.88, and the predictive power was higher than that of the liver SWV (AUROC: 0.71, Z= 2.5, P= 0.025). Conclusion The sclerotherapy of the liver can significantly increase the SWV of the liver. The application of VTQ technique to measure the liver and spleen SWV can evaluate the curative effect of subsurgical sclerotherapy to a certain extent. The evaluation efficacy of spleen SWV is higher than that of liver SWV which means it has certain potential value for affecting the clinical efficacy of EV sclerotherapy.

Key words: Esophageal varices, Cirrhosis, Ultrasonography, Elastography, Real-time shear wave elastography